SEC CIK 1511491
Finucane Anne A.
Reported ownership across 2 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| WSMview stock → | 9,404 | 2026-10-16 |
| CVSview stock → | 591 | 2025-11-20 |
Position History — CVS
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — CVS
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-05-14 | Grant / award (derivative) | 1,544.004 | $97.15 | 18,355.036 |
| 2025-11-20 | Grant / award (derivative) | 1,775.38 | $76.04 | 16,530.06 |
| 2025-11-20 | Grant / award | 591 | $76.04 | 591 |
| 2025-08-20 | Open-market sale | 7,500 | $71.02 | 22,156 |
| 2025-05-15 | Grant / award (derivative) | 2,077.48 | $60.47 | 14,513.27 |
| 2025-05-15 | Grant / award | 692 | $60.47 | 692 |
| 2024-12-05 | Gift | 2,665 | $56.86 | 4,567.25 |
| 2024-11-21 | Grant / award (derivative) | 2,200.09 | $57.10 | 12,173.16 |
| 2024-05-16 | Grant / award (derivative) | 2,184.02 | $57.52 | 9,747.66 |
| 2023-12-07 | Gift | 3,450 | $74.28 | 7,232.25 |
| 2023-11-15 | Grant / award | 1,925 | $69.13 | 10,682.25 |
| 2023-05-18 | Grant / award | 1,437 | $69.31 | 8,757.25 |
| 2022-11-18 | Gift | 800 | $97.35 | 28,964 |
| 2022-11-17 | Grant / award | 1,428 | $94.93 | 7,320.25 |
| 2022-05-11 | Grant / award | 1,384 | $97.99 | 5,892.25 |
| 2021-11-17 | Grant / award | 1,314 | $92.73 | 1,314 |
| 2021-05-13 | Grant / award | 1,446 | $84.27 | 1,446 |
| 2020-11-18 | Grant / award (derivative) | 1,836.85 | $66.35 | 9,959.82 |
| 2020-05-14 | Grant / award (derivative) | 1,955.95 | $62.31 | 7,991.07 |
| 2019-11-20 | Grant / award | 1,551 | $74.92 | 1,551 |
| 2019-05-16 | Grant / award | 2,222 | $52.30 | 2,222 |
| 2018-11-07 | Grant / award | 1,332 | $78.77 | 1,332 |
| 2018-06-04 | Grant / award | 1,638 | $64.10 | 1,638 |
| 2017-11-08 | Grant / award (derivative) | 1,521.96 | $68.99 | 5,586 |
| 2017-05-10 | Grant / award (derivative) | 1,297.26 | $80.94 | 4,009.4 |
| 2016-11-02 | Grant / award | 1,250 | $83.95 | 1,250 |
| 2016-05-19 | Grant / award | 1,040 | $100.95 | 1,040 |
| 2016-01-04 | Open-market sale | 2,000 | $95.87 | 14,719 |
| 2015-11-25 | Gift | 600 | $93.90 | 16,719 |
| 2015-11-04 | Grant / award | 1,406 | $99.57 | 1,406 |
| 2015-05-07 | Grant / award | 1,409 | $99.36 | 1,409 |
| 2014-11-05 | Grant / award (derivative) | 1,200 | $87.50 | 2,593.54 |
| 2014-05-08 | Grant / award (derivative) | 1,384.13 | $75.86 | 1,384.13 |
| 2013-11-06 | Grant / award | 1,526 | $63.87 | 1,526 |
| 2013-05-09 | Grant / award | 1,695 | $57.49 | 1,695 |
| 2013-04-15 | Open-market sale | 500 | $57.24 | 11,283 |
| 2012-11-08 | Grant / award | 2,099 | $46.43 | 2,099 |
| 2012-09-17 | Open-market sale | 1,000 | $46.87 | 9,684 |
| 2012-05-10 | Grant / award | 2,120 | $45.97 | 10,684 |
| 2011-11-02 | Grant / award | 3,407 | $35.77 | 8,564 |
| 2011-05-11 | Grant / award | 3,250 | $37.50 | 5,157 |
| 2011-03-09 | Grant / award | 1,907 | $34.07 | 1,907 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.